HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Treatment of primary fibromyalgia with Rheumajecta and Vasolastine; results of a randomized, placebo-controlled, double-blind study].

AuthorsA J Nollen
JournalNederlands tijdschrift voor geneeskunde (Ned Tijdschr Geneeskd) Vol. 134 Issue 21 Pg. 1062-3 (May 26 1990) ISSN: 0028-2162 [Print] Netherlands
Vernacular TitleBehandeling met Rheumajecta en Vasolastine van primaire fibromyalgie; resultaten van een gerandomiseerd, placebo-gecontroleerd, dubbelblind onderzoek.
PMID2164164 (Publication Type: Clinical Trial, Letter, Randomized Controlled Trial)
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • Drug Combinations
  • Rheumajecta
  • vasoelastine
  • Catalase
  • Lipoxygenase
  • Choline O-Acetyltransferase
  • Nucleotidyltransferases
  • Sulfate Adenylyltransferase
  • Sulfurtransferases
  • Lipase
Topics
  • Anti-Inflammatory Agents, Non-Steroidal (therapeutic use)
  • Catalase (therapeutic use)
  • Choline O-Acetyltransferase (therapeutic use)
  • Double-Blind Method
  • Drug Combinations (therapeutic use)
  • Fibromyalgia (drug therapy)
  • Humans
  • Lipase (therapeutic use)
  • Lipoxygenase (therapeutic use)
  • Nucleotidyltransferases (therapeutic use)
  • Randomized Controlled Trials as Topic
  • Sulfate Adenylyltransferase (therapeutic use)
  • Sulfurtransferases (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: